GHK-Cu 100mg

GHK-Cu is a copper-binding tripeptide (glycyl-L-histidyl-L-lysine:Cu²⁺) present endogenously in human plasma, saliva and urine, with circulating concentrations diminishing measurably with age. The literature characterises its influence on extracellular matrix remodelling, fibroblast activation and broad transcriptomic modulation across genes linked to repair, antioxidant defence and angiogenesis. The 100mg presentation positions it for extended dermal regeneration and gene-expression research programmes.

Supplied as a lyophilised peptide vial, supplied for reconstitution with bacteriostatic water. The 100mg size suits institutional laboratories, extended multi-cohort dermal protocols and longitudinal extracellular matrix studies where the larger format delivers superior unit cost and reduces inter-batch variability.

Research Applications • Extended extracellular matrix and fibroblast activation studies • Multi-cohort dermal regeneration and wound-healing investigation • Longitudinal transcriptomic profiling and gene-expression research • Sustained angiogenesis and copper-mediated redox-pathway assays

Specification • Identity: GHK-Cu / Copper Tripeptide-1 (CAS 49557-75-7) • Molecular weight: 403.93 g/mol • Purity: 99%+ verified by HPLC and Mass Spectrometry • Format: lyophilised peptide vial — reconstitute with bacteriostatic water before use • Storage: store lyophilised at -20°C; once reconstituted, refrigerate at 2-8°C and use within 4-6 weeks; protect from light

For research use only — not for human consumption.